Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-16
P
Pritmohinder S. Gill
High Impact
Associate Professor
Faculty Researcher
21 h-index
47 pubs
2,197 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Pritmohinder S. Gill's research investigates the molecular underpinnings of neurodevelopmental disorders, with a particular focus on autism spectrum disorder (ASD). His work utilizes integrated transcriptomic profiling, examining both mRNA and microRNA expression, to identify novel targets and networks associated with these conditions. Recent publications explore the role of microRNAs in immunomodulation within ASD and the transcriptomic signatures of mitochondrial dysfunction in affected individuals.
His research also extends to the practical implementation of pharmacogenomics in clinical settings. Gill has contributed to studies assessing the integration of pharmacogenomics into multidisciplinary teams, including experiences at Arkansas Children’s Hospital. His scholarship metrics include an h-index of 21, with over 2,193 total citations across 47 publications, designating him as a highly cited researcher. Key collaborators include Shannon Rose and Jeffery L. Clothier from the University of Arkansas for Medical Sciences.
Metrics
- h-index: 21
- Publications: 47
- Citations: 2,197
Selected Publications
-
Transcriptomic Signatures of Mitochondrial Dysfunction in Autism: Integrated mRNA and microRNA Profiling (2025)
-
Pharmacogenetics (2024)
-
Contributors (2024)
-
Integrated microRNA–mRNA Expression Profiling Identifies Novel Targets and Networks Associated with Autism (2022)
-
Identification of DCAF1 by Clinical Exome Sequencing and Methylation Analysis as a Candidate Gene for Autism and Intellectual Disability: A Case Report (2022)
-
Multidisciplinary Consulting Team for Complicated Cases of Neurodevelopmental and Neurobehavioral Disorders: Assessing the Opportunities and Challenges of Integrating Pharmacogenomics into a Team Setting (2022)
-
MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation (2021)
-
Molecular Dysregulation in Autism Spectrum Disorder (2021)
-
Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital (2021)
-
Acetaminophen is both bronchodilatory and bronchoprotective in human precision cut lung slice airways (2018)
-
Acylcarnitines as Translational Biomarkers of Mitochondrial Dysfunction (2018)
-
Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans (2017)
-
Autistic Siblings with Novel Mutations in Two Different Genes: Insight for Genetic Workups of Autistic Siblings and Connection to Mitochondrial Dysfunction (2017)
-
MicroRNA regulation of CYP 1A2, CYP3A4 and CYP2E1 expression in acetaminophen toxicity (2017)
-
Metabolomics Analysis of Urine Samples from Children after Acetaminophen Overdose (2017)
Collaboration Network
Top Collaborators
Patricia Porter‐Gill
Arkansas Children's Hospital (US)
8 shared publications
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Molecular Dysregulation in Autism Spectrum Disorder
- MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation
- Integrated microRNA–mRNA Expression Profiling Identifies Novel Targets and Networks Associated with Autism
- Multidisciplinary Consulting Team for Complicated Cases of Neurodevelopmental and Neurobehavioral Disorders: Assessing the Opportunities and Challenges of Integrating Pharmacogenomics into a Team Setting
Showing 5 of 8 shared publications
G. Bradley Schaefer
University of Arkansas for Medical Sciences (US)
4 shared publications
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Molecular Dysregulation in Autism Spectrum Disorder
- Multidisciplinary Consulting Team for Complicated Cases of Neurodevelopmental and Neurobehavioral Disorders: Assessing the Opportunities and Challenges of Integrating Pharmacogenomics into a Team Setting
- Identification of DCAF1 by Clinical Exome Sequencing and Methylation Analysis as a Candidate Gene for Autism and Intellectual Disability: A Case Report
Jeffery L. Clothier
University of Arkansas for Medical Sciences
3 shared publications
In database
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Molecular Dysregulation in Autism Spectrum Disorder
- Identification of DCAF1 by Clinical Exome Sequencing and Methylation Analysis as a Candidate Gene for Autism and Intellectual Disability: A Case Report
Harsh Dweep
The Wistar Institute (US)
3 shared publications
- Molecular Dysregulation in Autism Spectrum Disorder
- MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation
- Integrated microRNA–mRNA Expression Profiling Identifies Novel Targets and Networks Associated with Autism
Richard E. Frye
3 shared publications
- MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation
- Integrated microRNA–mRNA Expression Profiling Identifies Novel Targets and Networks Associated with Autism
- Transcriptomic Signatures of Mitochondrial Dysfunction in Autism: Integrated mRNA and microRNA Profiling
Shannon Rose
University of Tennessee Health Science Center
3 shared publications
In database
- MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation
- Integrated microRNA–mRNA Expression Profiling Identifies Novel Targets and Networks Associated with Autism
- Transcriptomic Signatures of Mitochondrial Dysfunction in Autism: Integrated mRNA and microRNA Profiling
Sandra McCullough
Arkansas Children's Hospital (US)
3 shared publications
- MicroRNA Expression Profiles in Autism Spectrum Disorder: Role for miR-181 in Immunomodulation
- Integrated microRNA–mRNA Expression Profiling Identifies Novel Targets and Networks Associated with Autism
- Transcriptomic Signatures of Mitochondrial Dysfunction in Autism: Integrated mRNA and microRNA Profiling
Feliciano Yu
University of Arkansas for Medical Sciences
2 shared publications
In database
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Pharmacogenetics
Aravindhan Veerapandiyan
Arkansas Children's Hospital
2 shared publications
In database
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Molecular Dysregulation in Autism Spectrum Disorder
Don Rule
Mercer Island School District (US)
2 shared publications
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Pharmacogenetics
Bobby L. Boyanton
Arkansas Children's Hospital
1 shared publication
In database
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
Judith Allen
Arkansas Children's Hospital (US)
1 shared publication
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
Jason E. Farrar
Arkansas Children's Hospital
1 shared publication
In database
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
Parthak Prodhan
Arkansas Children's Hospital
1 shared publication
In database
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
Kevin Bielamowicz
Arkansas Children's Hospital
1 shared publication
In database
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
Similar Researchers
Based on overlapping research topics
Allen Gies
University of Arkansas for Medical Sciences
MicroRNA in disease regulation
Bioinformatics and Genomic Networks
Mitochondrial Function and Pathology
J. Sharman Mathew
University of Arkansas at Fayetteville
Bioinformatics and Genomic Networks
Mitochondrial Function and Pathology
Metabolism and Genetic Disorders
Hannah Stovall
Hendrix College
Mitochondrial Function and Pathology
Pharmacological Effects and Toxicity Studies
Metabolism and Genetic Disorders
Martin Radvany
University of Arkansas for Medical Sciences
Mitochondrial Function and Pathology
Pharmacological Effects and Toxicity Studies
Metabolism and Genetic Disorders
J.‐R. Chen
University of Arkansas for Medical Sciences
Mitochondrial Function and Pathology
Pharmacological Effects and Toxicity Studies
Metabolism and Genetic Disorders
H. Kenneth Spencer
University of Arkansas for Medical Sciences
Mitochondrial Function and Pathology
Pharmacological Effects and Toxicity Studies
Metabolism and Genetic Disorders